Autor:	Brubaker JED; Internal Medicine, Wright State University Boonshoft School of Medicine, Dayton, USA.; Internal Medicine, Wright-Patterson Air Force Base (AFB) Medical Center, Dayton, USA., Casaccio CL; Internal Medicine, Wright State University Boonshoft School of Medicine, Dayton, USA.; Internal Medicine, Wright-Patterson Air Force Base (AFB) Medical Center, Dayton, USA., Brazeau MJ; Gastroenterology, Wright-Patterson Air Force Base (AFB) Medical Center, Dayton, USA.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2022 May 25; Vol. 14 (5), pp. e25339. Date of Electronic Publication: 2022 May 25 (Print Publication: 2022).
DOI:	10.7759/cureus.25339
Abstrakt:	A 35-year-old Asian female with a pertinent past medical history of autoimmune hepatitis presented with an acute recurrence of autoimmune hepatitis two weeks after receiving the second dose of the Pfizer-BioNTech messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccine. Nine cases of autoimmune hepatitis after the administration of the COVID-19 vaccine have been reported, but this is the first documented case of a reactivation of autoimmune hepatitis in remission. As recommendations for COVID-19 vaccinations and booster shots continue to evolve, all adverse events should be reported to better educate and monitor patients. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2022, Brubaker et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu